期刊
NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41467-019-11004-3
关键词
-
资金
- NIH/NIAAA, USA [R01AA023781, UO1AA018663]
- Hepacare Project, Fundacion La Caixa, Spain
- Fond national de la recherche scientifique [FNRS J.0146.17]
- Fond de la recherche scientifique medicale, Belgium [FRSM T.0217.18]
- NIH/NCATS [UH3TR000503]
- EPA, USA [STAR 83573601]
- MRC, UK [MK/K001949/1]
- NIH/NIAAA [1U01AA021908-01-33490, 1U01AA021908, U01AA021908]
- Instituto de Salud Carlos III [PI17/00673]
- Una manera de hacer Europa program, European Regional Development Fund (ERDF), EU
- National Institute for Health Research Imperial Biomedical Research Centre
- NIHR Health Technology Assessment Grant [08-14-44]
- NIH T32, USA [DK007052]
- AFEF
- [CPII16/00041]
- MRC [MR/K001949/1, MR/M003132/1, MR/R023026/1] Funding Source: UKRI
Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound hepatocellular dysfunction for which targeted treatments are urgently needed. Identification of molecular drivers is hampered by the lack of suitable animal models. By performing RNA sequencing in livers from patients with different phenotypes of alcohol-related liver disease (ALD), we show that development of AH is characterized by defective activity of liver-enriched transcription factors (LETFs). TGF beta 1 is a key upstream transcriptome regulator in AH and induces the use of HNF4 alpha P2 promoter in hepatocytes, which results in defective metabolic and synthetic functions. Gene polymorphisms in LETFs including HNF4 alpha are not associated with the development of AH. In contrast, epigenetic studies show that AH livers have profound changes in DNA methylation state and chromatin remodeling, affecting HNF4 alpha-dependent gene expression. We conclude that targeting TGF beta 1 and epigenetic drivers that modulate HNF4 alpha-dependent gene expression could be beneficial to improve hepatocellular function in patients with AH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据